News

Published on 27 Apr 2024 on GuruFocus.com via Yahoo Finance

Decoding Carlisle Companies Inc (CSL): A Strategic SWOT Insight

Article preview image

Robust revenue growth with a significant increase from $892.6 million to $1,096.5 million year-over-year.Strong operational performance with operating income more than doubling to $225.2 million.Net income surge, showcasing a healthy rise from $101.7 million to $192.3 million.Strategic focus on building envelope solutions aligning with energy efficiency and sustainability trends.

Warning! GuruFocus has detected 6 Warning Sign with CSL.

Read the rest of the article
ASX.CSL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMari...

Zacks · via Yahoo Finance 27 Jan 2025
Is Carlisle Companies Incorporated (CSL) the Best Diversified Dividend Stock to...

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this articl...

Insider Monkey · via Yahoo Finance 23 Jan 2025
Is CSL Limited (ASX:CSL) Trading At A 30% Discount?

Key Insights CSL's estimated fair value is AU$408 based on 2 Stage Free Cash Flow to Equity CSL i...

Simply Wall St. · via Yahoo Finance 10 Jan 2025
Carlisle to Boost Product Portfolio With the Acquisition of ThermaFoam

Carlisle Companies Incorporated CSL recently announced that it has signed a definitive deal to...

Zacks · via Yahoo Finance 24 Dec 2024
Carlisle Buys Plasti-Fab & Enhances its Position in Polystyrene Market

Carlisle Companies Incorporated CSL recently completed the acquisition of the expanded polystyren...

Zacks · via Yahoo Finance 19 Dec 2024
Is It Too Late To Consider Buying Carlisle Companies Incorporated (NYSE:CSL)?

Carlisle Companies Incorporated (NYSE:CSL) saw a double-digit share price rise of over 10% in the...

Simply Wall St. · via Yahoo Finance 8 Dec 2024
EXEL vs. CSLLY: Which Stock Is the Better Value Option?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixi...

Zacks · via Yahoo Finance 21 Nov 2024
Decoding Carlisle Companies Inc (CSL): A Strategic SWOT Insight

Robust Revenue Growth: CSL reports a significant increase in revenues, marking a strong financial...

GuruFocus.com · via Yahoo Finance 26 Oct 2024
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi ...

Benzinga · via AOL 16 Oct 2024
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi ...

Benzinga · via Yahoo Finance 5 Oct 2024

Copyright Statfolio @ 2025

Social Accounts